Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Public ClinicalTrials.gov record NCT00228566. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Short-term (8 Week) Open-Label Study, Followed by a Long Term Evaluation, to Assess Patient-Reported Outcomes With Armodafinil Treatment (150 to 250 mg/Day) for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess patient reported outcomes with armodafinil treatment in terms of improvement in sleepiness, satisfaction with treatment, impact on ability to engage in life activities (ie, daily or work and family and/or social activities), and effects on fatigue. Clinician ratings on patient response to armodafinil treatment will also be assessed.
Study identification
- NCT ID
- NCT00228566
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 247 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2005 (Type not available)
- Primary completion
- Not listed
- Completion
- Jul 2006 (Actual)
- Last update posted
- Jul 19, 2013
2005 – 2006
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 40
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sleep Disorders Center of Alabama | Birmingham | Alabama | 35213 | — |
| Neurology Consultants of Tuscaloosa, P.C. | Tuscaloosa | Alabama | 35406 | — |
| Pulmonary Associates | Phoenix | Arizona | 85006 | — |
| HOPE Research Institute | Phoenix | Arizona | 85032 | — |
| PsyPharm Clinical Research | Phoenix | Arizona | 85050 | — |
| PsyPharm Clinical Research Inc. | Tucson | Arizona | 85712 | — |
| Neurology and Clinical Study Center | Little Rock | Arkansas | 72205 | — |
| Advanced Clinical Research Institute | Anaheim | California | 92801 | — |
| West Coast Clinical Trials, Inc | Long Beach | California | 90806 | — |
| Neuro-Therapeutics, Inc | Pasadena | California | 91105 | — |
| Penninsula Research Associates | Rolling Hills Estates | California | 90274 | — |
| Pacific Sleep Program | San Francisco | California | 94109 | — |
| The Sleep Disorders Center of Santa Barbara | Santa Barbara | California | 93103 | — |
| Colorado Sleep Disorder Center | Englewood | Colorado | 80113 | — |
| Clinical Research Group of St. Petersburg | St. Petersburg | Florida | 33707 | — |
| Child Neurology Associates, PC | Atlanta | Georgia | 30342 | — |
| Neurotrials, Inc. | Atlanta | Georgia | 30342 | — |
| Sleepmed Inc. | Macon | Georgia | 31201 | — |
| Savannah Neuurology | Savannah | Georgia | 31405 | — |
| Evanston Northwestern Healthcare, Evanston Hospital | Evanston | Illinois | 60201 | — |
| Convenant Clinic | Waterloo | Iowa | 50702 | — |
| Chest Medicine Assocaites d/b/a/ Sleep Medicine Specialists | Louisville | Kentucky | 40217 | — |
| Center for Sleep and Wake Disorders | Chevy Chase | Maryland | 20815 | — |
| Neurocare. Inc | Newton | Massachusetts | 02459 | — |
| Cumberland Research Associates | Fayetteville | North Carolina | 28304 | — |
| Neurology and Neuro Science Associates | Akron | Ohio | 44302 | — |
| North Coast Clinical Trials, Inc. | Beechwood | Ohio | 44122 | — |
| Jonathan Schwartz | Oklahoma City | Oklahoma | 73109 | — |
| Pacific Sleep Program | Portland | Oregon | 97209 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| Crozer Chester Medical Center | Upland | Pennsylvania | 19013 | — |
| University Services | West Chester | Pennsylvania | 19380 | — |
| SleepMed of South Carolina | Columbia | South Carolina | 29201 | — |
| Healthstar Physicians | Morristown | Tennessee | 37813 | — |
| Sleep Medicine of Tennesse | Nashville | Tennessee | 37205 | — |
| Metroplex Pulmonary and Sleep Center, PA | Allen | Texas | 75013 | — |
| FutureSearch Trials | Austin | Texas | 78756 | — |
| Sleep Medicine Associates of Texas, P.A | Plano | Texas | 75093 | — |
| Texas Association of Pediatric Neurology | San Antonio | Texas | 78258 | — |
| Vermont Medical Sleep Disorders Center | Essex Junction | Vermont | 05452 | — |
| Sleep Disorders Center of the Mid Atlantic | Vienna | Virginia | 22182 | — |
| Pacific Institute of Medical Science | Kirkland | Washington | 98034 | — |
| Pacific Institute of Mental Health | Seattle | Washington | 98133 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00228566, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2013 · Synced Oct 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00228566 live on ClinicalTrials.gov.